The efficacy of anti‐IL‐1 targeted therapy in PAPA and PASH syndrome

The efficacy of anti‐IL‐1 targeted therapy in PAPA and PASH syndrome

Abstract Introduction Pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) and pyoderma gangrenosum, acne and hidradenitis suppurativa (PASH) are rare autoinflammatory diseases. Treatment of PAPA and PASH is difficult. Conventional immunosuppressants and tumor necrosis factor (TNF) antagonists f...

Full description

Bibliographic Details
Main Authors: Chloé Challamel, Céline Girard, Laurent Misery, Assia Touhouche, Marion Fradet, Maëlla Severino‐Freire, Cristina B. Livideanu, Maria P. Konstantinou, Fatma Jendoubi, Carle Paul
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:JEADV Clinical Practice
Subjects:
anakinra
Canakinumab
PAPA syndrome
Pyoderma gangrenosum
Online Access:https://doi.org/10.1002/jvc2.52

Internet

https://doi.org/10.1002/jvc2.52

Similar Items